REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,541,000 | -14.7% | 1,462,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,806,000 | -27.6% | 1,462,000 | -45.0% | 0.00% | 0.0% |
| Q4 2022 | $2,494,000 | -10.3% | 2,660,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,780,000 | +1.2% | 2,660,000 | -15.5% | 0.00% | 0.0% |
| Q2 2022 | $2,747,000 | -11.9% | 3,148,000 | -5.5% | 0.00% | 0.0% |
| Q1 2022 | $3,118,000 | -12.0% | 3,332,000 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $3,544,000 | -37.5% | 4,047,000 | -17.9% | 0.00% | 0.0% |
| Q3 2021 | $5,669,000 | -1.5% | 4,932,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $5,754,000 | +5.2% | 4,932,000 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $5,471,000 | – | 4,882,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,242 | $14,728 | 1.18% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,978,000 | $17,262,586 | 0.72% |
| Graham Capital Management, L.P. | 31,929,000 | $25,650,931 | 0.60% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $4,034,417 | 0.55% |
| SSI INVESTMENT MANAGEMENT LLC | 6,877,000 | $5,527,733 | 0.45% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 20,000,000 | $16,176,767 | 0.41% |
| Nuveen Asset Management, LLC | 14,000,000 | $1,125,320,000 | 0.40% |
| CSS LLC/IL | 6,052,000 | $4,885,744 | 0.32% |
| Sonora Investment Management Group, LLC | 3,150,000 | $2,551,142 | 0.22% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,044,000 | 0.20% |